ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,548Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 36

$762K Total Retail Price of All Prescriptions

Rank: 9 out of 36

940 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 13,364 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
PRAVASTATIN SODIUM 1,477 1,339 1 9
ATORVASTATIN CALCIUM 968 873 2 10
LISINOPRIL 871 809 3 8
CARVEDILOL 857 769 4 1
HYDROCHLOROTHIAZIDE 822 810 5 15
METOPROLOL TARTRATE 799 773 6 12
CRESTOR 703 631 7 13
METOPROLOL SUCCINATE 549 525 8 5
SIMVASTATIN 536 489 9 3
BYSTOLIC 432 370 10 20
NIFEDIPINE ER 397 396 11 29
CLOPIDOGREL 392 340 12 2
VYTORIN 276 247 13 55
PLAVIX 274 257 14 7
FUROSEMIDE 235 225 15 6
WARFARIN SODIUM 234 223 16 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 229 202 17 50
FENOFIBRATE 222 188 18 49
AMLODIPINE BESYLATE 192 186 19 4
BENICAR 191 172 20 51
AMIODARONE HCL 170 163 21 22
LOSARTAN POTASSIUM 163 145 22 19
NIFEDICAL XL 157 130 23 67
LIPITOR 157 145 23 30
DOXAZOSIN MESYLATE 147 137 25 40
DIOVAN 143 129 26 18
CITALOPRAM HBR 142 131 27 72
DIGOXIN 131 109 28 16
ZETIA 123 106 29 25
BENICAR HCT 119 118 30 71
EFFIENT 119 108 30 42
ESCITALOPRAM OXALATE 109 102 32 97
ISOSORBIDE MONONITRATE ER 106 90 33 14
ATENOLOL 94 76 34 23
LOVAZA 91 88 35 46
SPIRONOLACTONE 79 71 36 26
RANITIDINE HCL 76 75 37 75
DIOVAN HCT 74 62 38 34
RANEXA 70 67 39 24
TRICOR 66 54 40 61
POTASSIUM CHLORIDE 63 51 41 17
PANTOPRAZOLE SODIUM 59 50 42 43
TRIAMTERENE-HCTZ 57 55 43 56
LOSARTAN-HYDROCHLOROTHIAZIDE 55 52 44 47
RAMIPRIL 54 54 45 21
PACERONE 53 53 46 89
OMEPRAZOLE 51 35 47 31
CLONIDINE HCL 50 50 48 28
KLOR-CON M20 50 43 48 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.